OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Neurology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Headache in infections	110
Learning from the comorbidities of epilepsy	103
Update on genetics of amyotrophic lateral sclerosis	57
Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis	52
Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and management	48
Congenital myasthenic syndromes: increasingly complex	48
The genetics of amyotrophic lateral sclerosis	47
Update on neuroimaging in brain tumours	45
New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome	44
Understanding multiple sclerosis as a disease spectrum: above and below the clinical threshold	37
Promises and pitfalls of imaging-based biomarkers in motor neuron diseases	33
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	32
The recent surge of functional movement disorders: social distress or greater awareness?	31
Sudden unexpected death in epilepsy	31
Traumatic brachial plexus injury: diagnosis and treatment	27
Deciphering the contributions of neuroinflammation to neurodegeneration: lessons from antibody-mediated encephalitis and coronavirus disease 2019	26
Neuropathology and neuroanatomy of TDP-43 amyotrophic lateral sclerosis	25
Rescue therapies in epilepsy	23
Intravenous thrombolysis for acute ischemic stroke: why not?	23
Editorial introductions	22
Advanced neuroimaging techniques in epilepsy	22
Editorial introductions	21
Editorial: Clinical epileptology entering the era of personalized medicine	21
Insights into a personalized management of blood pressure in acute stroke	20
Primary central nervous system vasculitis and headache: Ten themes	19

Update on neuroimaging in Alzheimer's disease	19
MRI and laboratory monitoring of disease-modifying therapy efficacy and risks	19
Cancer stem cells in gliomas: evolving concepts and therapeutic implications	19
Editorial: Current opinions in neurology editorial	18
Endogenous clues promoting remyelination in multiple sclerosis	18
Autoimmune movement disorders with neuronal antibodies – an update	18
Neuropathogenesis of acute coronavirus disease 2019	17
PET-based brain molecular connectivity in neurodegenerative disease	17
Editorial: Neuromuscular diseases: differential diagnosis and targeted treatment	17
Highly effective disease-modifying treatment as initial MS therapy	17
Neuropathology and epilepsy surgery	17
Neuromuscular complications of cancer therapy	17
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	17
Visually induced dizziness	16
Editorial introductions	16
Sinus, disabling tension-type, and temporomandibular joint headaches	16
Targeting B cells in multiple sclerosis	16
Hypoventilation syndrome in neuromuscular disorders	16
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	15
The state of art on the use of patient reported outcomes in migraine	15
Pregnancy and reproductive health in women with multiple sclerosis: an update	15
Editorial: Degenerative and cognitive diseases	15
Reproducibility and replicability in neuroimaging data analysis	14
Chemotherapy and targeted therapies for meningiomas: what is the evidence?	14
Diagnosing viral encephalitis and emerging concepts	14
An update on the role of focused ultrasound in neuro-oncology	14
Fluid phase biomarkers in multiple sclerosis	14
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	14
Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications	13
Socioeconomic disparities in epilepsy care	13
Abnormal energy metabolism in ALS: a key player?	13
The optic nerve in spaceflight: novel concepts in the pathogenesis of optic disc edema in microgravity	13
Current trend in air pollution exposure and stroke	13
Central vestibular networking for sensorimotor control, cognition, and emotion	13
Cerebral amyloid angiopathy: one single entity?	13
Update on management of cerebral venous thrombosis	13
Guillain-Barré syndrome in an era of global infections and 21st century vaccination	13
Management of neuropsychiatric symptoms in dementia	12
Addressing vaccine-preventable encephalitis in vulnerable populations: Erratum	12
Neurology education in the era of artificial intelligence	12
Pharmacological treatment for older adults with epilepsy and comorbid neurodegenerative disorders	12
An update on Becker muscular dystrophy	12
Old muscle, new tricks: a clinician perspective on sarcopenia and where to next	12
Hereditary motor neuropathies	12
Recent advances in our understanding of genetic rhabdomyolysis	12
Recent insights in striated muscle laminopathies	12
Recent insights into haematology and peripheral nerve disease	12
Diagnostic criteria for amyotrophic lateral sclerosis	12
Imaging cortical lesions in multiple sclerosis	11
Noninvasive neuromodulation and rehabilitation to promote functional restoration in persons with spinal cord injury	11

Vestibular contribution to spatial orientation and navigation	11
Parkinson's disease – current treatment	11
Artificial intelligence and machine learning in disorders of consciousness	11
Contraception, fecundity, and pregnancy in women with epilepsy: an update on recent literature	11
Historical development and contemporary use of neuromodulation in human spinal cord injury	11
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	10
Update on modifiable risk factors for Alzheimer's disease and related dementias	10
New knowledge on anti-IgLON5 disease	10
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	10
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies	10
Myoclonus: an update	10
Precision medicine in secondary prevention of ischemic stroke: how may blood-based biomarkers help in clinical routine? An expert opinion	10
Neuroscience and oncology: state-of-the-art and new perspectives	9
Visual snow syndrome: recent advances in understanding the pathophysiology and potential treatment approaches	9
Sleep and circadian rhythm dysfunctions in movement disorders beyond Parkinson's disease and atypical parkinsonisms	9
Advances in functional and structural imaging of the brainstem: implications for disease	9
Editorial introductions	9
Noninvasive methods to monitor intracranial pressure	9
Bilateral vestibulopathy: the causes, diagnosis, and treatments	9
Toxin-associated infectious diseases: tetanus, botulism and diphtheria	9
Neurological adverse events of immune checkpoint blockade: from pathophysiology to treatment	8
Traumatic peripheral nerve injuries: diagnosis and management	8
Editorial introductions	8
Editorial: Making the invisible visible: updates on vestibular neurology	8
The role of caffeine in headache disorders	8
What have we learned from cognition in the oldest-old	8
Editorial introductions	8
Seizure prediction and forecasting: a scoping review	8
A patient with neuropathy and ataxia: what do I have to consider?	8
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	8
Prevention of epileptogenesis – are we there yet?	8
The atypical faces of optic neuritis: neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease	8
Vector-borne protozoal infections of the CNS: cerebral malaria, sleeping sickness and Chagas disease	8
Therapeutic developments for valosin-containing protein mediated multisystem proteinopathy	8
Triggers of migraine: where do we stand?	8
Central nervous system adverse events of immune checkpoint inhibitors	8
Emerging infectious encephalitides	8
Epidemiology and genetics of Meniere's disease	8